Reklaim Ltd. Reports Q3 2026 Revenue of $3.16 Million, Up 187%, and Net Income of $1.27 Million
Gross margin reached 87.2%, while nine-month operating cash flow totalled C$1,733,522.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Reklaim (OTCQB: MYIDF) reported third-quarter 2026 revenue of C$3,156,313, up 187.1% from the same period last year. Revenue rose 19.9% from Q2. Net income was C$1,272,063, up 76.0% sequentially, versus a C$514,636 loss a year earlier, marking its third consecutive profitable quarter.
Gross profit reached C$2,752,814, up 232.8% year over year and 36.5% sequentially. Gross margin rose to 87.2% from 75.3% a year earlier and 76.6% in Q2. Operating expenses increased 12.2% year over year and 15.7% sequentially to C$1,506,070.
For the nine months ended September 30, 2026, revenue was C$7,592,647, net income C$2,359,914 and operating cash flow C$1,733,522. Reklaim cancelled 5,149,000 repurchased shares on October 5, bringing total cancellations to 11,275,000 shares. Its U.S. trading market upgraded from OTC Pink to OTCQB; MYIDF remains unchanged. All financial amounts are in Canadian dollars.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointQ3 revenue of C$3,156,313 rose 187.1% year over year and 19.9% sequentially.
- Moderate pointQ3 net income of C$1,272,063 rose 76.0% sequentially, versus a C$514,636 prior-year loss.
- Moderate pointQ3 gross profit of C$2,752,814 increased 232.8% year over year and 36.5% sequentially.
- Moderate pointQ3 gross margin of 87.2% exceeded 75.3% a year earlier and 76.6% in Q2.
- Moderate pointNine-month operating cash flow totalled C$1,733,522 for the period ended September 30, 2026.
4 minor points
- Minor pointNine-month revenue totalled C$7,592,647 for the period ended September 30, 2026.
- Minor pointNine-month net income reached C$2,359,914 for the period ended September 30, 2026.
- Minor point5,149,000 repurchased shares were cancelled October 5, bringing total cancellations to 11,275,000 shares.
- Minor pointU.S. trading market upgrade moved Reklaim from OTC Pink to the OTCQB Venture Market.
Negative
- Moderate pointQ3 operating expenses of C$1,506,070 increased 12.2% year over year and 15.7% sequentially.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Net income rises
Toronto, Ontario--(Newsfile Corp. - November 3, 2026) - Reklaim Ltd. (TSXV: MYID) (OTCQB: MYIDF) ("Reklaim" or the "Company"), a consumer data privacy and monetization platform that enables individuals to access, control, remove and monetize their personal data, today reported financial results for the three and nine months ended September 30, 2026. All financial amounts are in Canadian dollars.
Reklaim generated quarterly revenue of
Net income reached
Gross profit increased
During Q3 2026, the Company repurchased 5,149,000 common shares under its Normal Course Issuer Bid (NCIB), bringing total repurchases for the first nine months of 2026 to 11,275,000 common shares. Subsequent to quarter-end, on October 5, 2026, the Company cancelled the 5,149,000 shares repurchased during Q3, bringing total cancellations to 11,275,000 common shares.
For the first nine months of 2026, Reklaim generated
Q3 2026 Financial Results
- Revenue increased
187.1% to$3,156,313 from$1,099,363 in Q3 2025. - Gross profit increased
232.8% to$2,752,814 from$827,259 in Q3 2025. - Gross margin expanded to
87.2% , compared with75.3% in Q3 2025 and76.6% in Q2 2026. - Operating expenses totalled
$1,506,070 , an increase of12.2% from$1,342,472 in Q3 2025. - Net income was
$1,272,063 , compared with a net loss of$514,636 in Q3 2025, marking Reklaim's third consecutive profitable quarter.
U.S. Trading Market Upgrade
Reklaim upgraded its U.S. trading market from OTC Pink to the OTCQB Venture Market, increasing visibility among U.S. investors and supporting the Company's efforts to broaden its shareholder base.
Reklaim's U.S. trading symbol, MYIDF, remains unchanged.
Financial Disclosure
Readers should review these results together with Reklaim's unaudited interim consolidated financial statements and accompanying notes, and its MD&A for the three and nine months ended September 30, 2026. Company financial disclosure and investor information can be accessed through Reklaim Investor Relations and SEDAR+.
About Reklaim
Reklaim Ltd. (TSXV: MYID) (OTCQB: MYIDF) is a consumer data privacy and monetization platform that returns control of personal information to individuals. Consumers can access, manage, remove, or choose to earn from their data, while Reklaim provides consumer-permissioned data solutions to brands, agencies, platforms and enterprise partners. The Company generates revenue through data licensing, audience activation, and enterprise data partnerships.
For more information, visit reklaimyou.com or Reklaim Investor Relations.
Investor Contact
Reklaim Ltd.
Investor Relations: https://reklaimyou.com/investors
investorrelations@reklaimyours.com
Forward-Looking Statements
This news release includes certain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. Forward-looking statements are not historical facts, are made as of the date of this news release and include, without limitation, statements concerning the Company's growth strategy and the anticipated benefits of the OTCQB market upgrade. These forward-looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, the risk that the anticipated benefits of the OTCQB market upgrade are not realized, fluctuations in quarterly revenue and operating results, changes in privacy laws and enforcement, restrictions affecting data categories or permitted uses, changes in browser or partner policies, competition, customer demand, market prices, working capital requirements, the continued availability of capital and financing, and general economic, market or business conditions. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including, without limitation, assumptions regarding customer demand, consumer participation, partner access, regulatory developments, prevailing market conditions, general business, economic, competitive, political and social conditions, the continued availability of capital and financing, and the ability of the Company to execute and achieve its business objectives.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those expressed or implied in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company's financial results for the three and nine months ended September 30, 2026 are not necessarily indicative of results that may be expected for any future period. Forward-looking statements are provided for the purpose of assisting readers in understanding management's current expectations regarding the matters described in this news release, and readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statements contained in this news release, except as required by applicable securities laws. Readers are encouraged to read the Company's continuous disclosure documents, including the risk factors described in its most recent management's discussion and analysis, available under the Company's SEDAR+ profile at www.sedarplus.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/322109
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Reklaim's Q3 2026 revenue and net income?
Reklaim reported C$3,156,313 in revenue and C$1,272,063 in net income for Q3 2026. Revenue increased 187.1% year over year and 19.9% sequentially. Net income rose 76.0% from Q2, compared with a C$514,636 loss in Q3 2025.
How did Reklaim's gross margin change in Q3 2026?
Reklaim's gross margin increased to 87.2% in Q3 2026, compared with 75.3% in Q3 2025 and 76.6% in Q2 2026. Gross profit reached C$2,752,814, up 232.8% year over year and 36.5% sequentially.